PP
BLUE

PDT Partners’s bluebird bio BLUE Stock Holding History

PDT Partners’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,954
Closed -$1.1M – 582
2022
Q4 		$1.1M Sell
7,954
-5,184
-39% -$730K 0.18% 194
2022
Q3 		$1.66M Sell
13,138
-12,836
-49% -$1.45M 0.25% 91
2022
Q2 		$2.15M Hold
25,974
– – 0.19% 158
2022
Q1 		$2.52M Buy
25,974
+10,831
+72% +$1.43M 0.22% 126
2021
Q4 		$3.02M Buy
15,143
+1,888
+14% +$446K 0.23% 155
2021
Q3 		$3.28M Buy
13,255
+6,492
+96% +$1.86M 0.24% 190
2021
Q2 		$2.8M Buy
6,763
+2,162
+47% +$857K 0.19% 228
2021
Q1 		$1.8M Sell
4,601
-2,001
-30% -$985K 0.13% 279
2020
Q4 		$3.7M Buy
6,602
+1,096
+20% +$695K 0.25% 180
2020
Q3 		$3.85M Sell
5,506
-894
-14% -$697K 0.25% 155
2020
Q2 		$5.06M Sell
6,400
-1,621
-20% -$1.22M 0.34% 117
2020
Q1 		$4.78M Hold
8,021
– – 0.38% 92
2019
Q4 		$9.12M Buy
+8,021
New +$8.72M 0.56% 60
2014
Q3 		– Sell
-805
Closed -$402K – 1312
2014
Q2 		$402K Buy
+805
New +$258K 0.01% 1092

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PDT Partners's BLUE Position: Q1 2023 in Review

PDT Partners sold out of bluebird bio (BLUE) in Q1 2023, closing a stake of 7,954 shares — an estimated $1.1M sold.

PDT Partners first reported a position in BLUE in Q2 2014 and held it in 14 quarters. The position peaked at $9.12M in Q4 2019. 177 funds tracked by Wall St. Rank hold BLUE as of Q1 2023.

  • PDT Partners reported no remaining bluebird bio position as of Q1 2023 after selling out during the quarter.
  • PDT Partners sold 7,954 bluebird bio shares in Q1 2023, an estimated $1.1M.
  • PDT Partners first reported a position in bluebird bio in Q2 2014 and held it in 14 quarters.
  • PDT Partners's bluebird bio position peaked at $9.12M in Q4 2019.
  • 177 funds tracked by Wall St. Rank held bluebird bio as of Q1 2023.

Based on PDT Partners's 13F filing for Q1 2023, filed 15 May 2023.